Effector pathways in immune mediated central nervous system demyelination

Bernd C. Kieseier, Maria K. Storch, Juan J. Archelos, Gianvito Martino, Hans Peter Hartung

Research output: Contribution to journalArticlepeer-review


Multiple sclerosis is generally regarded to be a primarily T-cell driven disease. Recent evidence has refocused interest on antibodies. Adhesion molecules, matrix metalloproteinases, chemokines and cytokines, and nitric oxide and oxygen metabolites all participate in the amplification and effector stages of the disease.

Original languageEnglish
Pages (from-to)323-336
Number of pages14
JournalCurrent Opinion in Neurology
Issue number3
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'Effector pathways in immune mediated central nervous system demyelination'. Together they form a unique fingerprint.

Cite this